A fluorescent bisboronic acid compound that selectively labels cells expressing oligosaccharide Lewis X by Gao, Xingming et al.
A fluorescent bisboronic acid compound that selectively labels 
cells expressing oligosaccharide Lewis X
Xingming Gaoa, Mengyuan Zhua, Haiying Fanb, Wenqian Yanga, Weijuan Nia, Vishnu V. R. 
Karnatia, Shouhai Gaoa, John Carsonb, Brent Westonb,*, and Binghe Wanga,*
aDepartment of Chemistry and Center for Diagnostics and Therapeutics, Georgia State 
University, Atlanta, GA 30303, USA
bDepartment of Pediatrics, University of North Carolina, Chapel Hill, NC 27599-7220, USA
Abstract
Two fluorescent diboronic acid compounds (6a and 6b) with a dipeptide linker were synthesized 
as potential sensors for cell surface saccharide Lewis X (LeX). Compound 6a with a dipeptide (H-
Asp-Ala-) as the linker was found to selectively label CHOFUT4 cells, which express Lex, at 
micromolar concentrations, while non-Lex-expressing control cells were not labeled.
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The cell surface carbohydrates of Lewis blood group antigens, Lewis X (Lex), Lewis Y 
(Ley), Lewis A (Lea), Lewis B (Leb), and their sialylated derivatives (e.g. sialy Lewis X 
(sLex)) that contain the fucose moiety play important roles in various types of biochemical 
recognition processes. These cell surface carbohydrates have also been associated with the 
development and progression of many types of cancers.1–4
The Lex structure (Figure 1), a trisaacharide Galβ(1–4)[Fucα(1–3)]GlcNAcβ-1, is present in 
a variety of normal and malignant human tissues.5 While the precise physiological role of 
Lex is still unknown, some insight has been gained regarding its biological activity. It has 
© 2015 Published by Elsevier Ltd.
*Corresponding authors. wang@gsu.edu (B. Wang) and bwwmd@med.unc.edu (B. Weston). 
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
HHS Public Access
Author manuscript
Bioorg Med Chem Lett. Author manuscript; available in PMC 2016 June 15.
Published in final edited form as:













been shown that the expresion of the Lex antigen varies greatly during the maturation of 
normal human cell.6 Therefore, Lex is believed to play a role in normal cell development 
and differentiation.7 The Lex antigen is also presumably associated with the growth of 
malignant cells because many human cancer tissues accumulate this antigen.8 Furthermore, 
Lex determinant may function as a recognition structure for endogenous receptors and 
adhesion molecules such as lectins that are a class of proteins of non-immune origin and 
bind carbohydrates specifically and noncovalently.9 Additionally, it was suggested that Lex 
may be related to learning dysfunction in some patients with mental retardation.10 Finally, 
there is evidence that the Lex determinant may play a role in inflammatory responses.11 
Since the Lex determinant is believed to be very pathologically important, the development 
of compounds (sensors) that selectively recognize Lex could help the diagnosis and early 
detection of various diseases. Such compounds could also aid in interpreting the binding of 
Lex with different receptors and therefore aid in the development drugs that act as inhibitors 
of the binding and activity of Lex.
Boronic acids have been known for decades to bind saccharides via reversible covalent 
interactions.12–14 The most common interactions are with linear diols, cis-1,2-diols on five-
membered rings, or 1,3-diols to form five- or six-membered rings, respectively. Therefore, 
carbohydrate sensing work during the last decade has been focused on using boronic acid as 
the basic recognition moiety.15–17 Our laboratory has been particularly interested in the 
development of fluorescent sensors for biologically important carbohydrates.18–21 For the 
construction of fluorescent sensors for cell surface carbohydrates, we envision that 
bisboronic acid compounds with a proper spatial arrangement of the two boronic acid 
moieties, which are complementary to the multiple pairs of diols, have the potential for 
selective recognition of the target carbohydrate. In doing so, we have selected Shinkai’s 
anthracene-based fluorescent boronic acid as the binding and reporting unit22 and have 
sampled a series of linkers with different length, rigidity, and spatial orientation in search of 
an optimal arrangement of the two boronic acid units. In our previous work, we reported a 
boronic acid-based fluorescent sensor that could selectively label sLex.18–20 The same 
sensor was found to be useful in mass spectrometric imaging work for cancer tissues.21 
Herein, we report a fluorescent boronic acid compound (6a) that selectively label Lex, which 
was derived from screening a large number of analogs with a range of boron-boron distance 
considered as appropriate for recognition of Lex. The computational aspect of this study is 
addressed later.
Compounds 6a and 6b contain the dipeptides H-Asp-Ala and H-Glu-Ala, respectively, as 
dicarboxylic acid linkers. The synthesis of these two compounds is shown in Scheme 1. The 
anthracence-based amine 1 was prepared by following a procedure reported previously.19 
Compounds 3a and 3b were obtained through a coupling reaction of the anthracence-based 
amine 1 with Fmoc protected dipeptide acids 2a and 2b, respectively.19 After Boc 
deprotection of compound 3 (3a and 3b) with trifuoroacetic acid (TFA), the unprotected free 
amines were then reacted with boronate 4 in the presence of potassium carbonate to give the 
diboronic acid compound 5 (5a and 5b).20 The final product 6 (6a and 6b) was obtained 
through deprotection of the Fmoc group with diethylamine in CH2Cl2.21
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Flow cytometry analysis of hepatocellular carcinoma (HCC) lines with anti-carbohydrate 
monoclonal antibodies was performed to characterize surface glycan expression. Cell lines 
were prepared and stained with monoclonal anti-carbohydrate antibodies at saturating 
concentrations as described.23,24 Cells were analyzed on a Becton-Dickinson FACS as 
previously described.24 The results indicated that CHOFUT4 expresses Lex only; Chinese 
hamster ovary (CHO) cell line does not express any glycans; HEP3B predominantly express 
Ley; B16FUT3 expresses sialyl Lewis a (sLea) only; COLO205 expresses sLex and sLea, but 
not Lex.
Compounds 6a and 6b were examined for their ability to label cells that express different 
carbohydrates. The fluorescent labeling studies were carried out in a cell culture system 
using these cells following previous described procedures.19 The plates containing the 
labeled cells were examined with phase contrast microscopy followed by fluorescent 
microscopy (blue cube wavelengths 370 nm excitation, 426 nm emission; 20 × lens). Plates 
were photographed and images were captured with the Nikon ACT-1 program (v 2.10). The 
phase contrast and fluorescent images were then overlaid, organized and labeled using 
Adobe Photoshop. The fluorescence intensity is displayed with mean gray value: black 
represents low signal intensity and white represents high signal intensity. The units (mean 
gray value) were subtracted from background, where there are no cells. The fluorescent 
signal was stable for at least 96 h when cells were maintained in darkness.
Figure 2 shows the mean gray value of different cells after incubation with fluorescent 
boronic acid compound 6a. As discussed above, larger mean gray values mean stronger 
fluorescence intensity. It is well known that the fluorescence intensity of boronic acid 
compounds such as 6a would increase after binding with a sugar. It is clear from Figure 2 
that CHO that does not express the target carbohydrates shows almost no fluorescence; 
HEP3B, B16FUT3 and COLO205 that express Ley, sLea, and sLex (and sLea), respectively, 
show weak fluorescence; CHOFUT4 that express Lex shows the highest fluorescence. These 
results indicated that compound 6a recognize Lex with selectivity over Ley, sLex, and sLea.
Figure 3 shows representative images of cell-labeling studies. Compared with the control 
cell CHO that does not express any glycans, the fluorescence of CHOFUT4 that express 
only Lex increased significantly after incubatation with compound 6a. Compound 6a 
selectively stained CHOFUT4 at the concentrations of both 2 and 8 µM. Furthermore, 
compound 6a only slightly stained HEP3B, B16FUT3, and COLO205 that expresses other 
carbohydrates such as Ley, sLex, and sLea (Figure 4).
The labeling of these cells using compound 6b was also studied. The results indicated that 
compound 6b did not show significant labeling of these antigens (data not shown). 
Compound 6a and 6b have a very similar molecular structure. The only structural difference 
between 6a and 6b is in their linker: compound 6a has H-Asp-Ala as the linker, but 6b has 
H-Glu-Ala as the linker. These results suggest that a small structural change can 
significantly affect the ability of a sensor to bind a specific carbohydrate.
In order to understand the conformational features of compounds 6a and 6b that contribute 
to binding, we performed molecular dynamics simulations of compound 6a,b and Lex in an 
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explicit water model with Desmond3.6.25 As can be seen from Figure 5, the distance 
between the two boron atoms in compound 6a settled quickly to 5 Å in only 1 ns and stayed 
there for the duration of the entire simulation process (20 ns). However, the distance 
between the two boron atoms in compound 6b took quite a long time (5 ns) to reach 5 Å, 
which is similar to the boron distance in compound 6a. Furthermore, this distance fluctuated 
in 6b, but not in 6a. These boron atoms even went away from each other for the last 2 ns of 
simulation in 6b. The results suggested that 6a was able to maintain a stable conformaiton, 
which is probably favorable for binding. On the other hand, 6b was not able to stay in a 
conformation favorable for binding. However, because we have no structural evidence to 
indicate which way the boronic acids might bind with LeX. Therefore, no further 
computational work was conducted. Thus the computational work only gives hints as to why 
6a exibits selectivity.
In conclusion, a fluorescent bisboronic acid compound 6a with a dipeptide linker has been 
developed to target Lex. Compound 6a was found to stain CHOFUT4 cells expressing Lex at 
micromolar concentrations. To the best of our knowledge, this is the first such synthetic 
receptor that has been found to fluorescently and selectively label cell expressing Lex.
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The structures of Lewis X (Lex) trisaccharide.
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Densitometry quantification of fluorescent intensity of cells upon incubation with compound 
6a. Cells were incubated with 2, 4, and 8 µM of 6a for 30 min. Mean gray values (y-axis) 
were determined after subtraction of cell-free background. CHOFUT4: Lex only; CHO: 
none of the glycans; HEP3B: predominantly Ley; B16FUT3: sLea only; COLO205: sLex 
and sLea, no Lex.
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Representative fluorescent labeling studies of compound 6a for CHOFUT4 and CHO cells. 
A: 6a at 2 µM for CHO; B: 6a at 2 µM for CHOFUT4. C: 6a at 8 µM for CHO; D: 6a at 8 
µM for CHOFUT4. λex = 370 nm, λem = 426 nm.
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Selectivity labeling studies of compound 6a. A: CHO (negative control) at 4 uM; B: CHO at 
8 uM; C: CHO-FUT4 (Lex-expressing) at 4 uM; D: CHO-FUT4 at 8 uM; E: COLO205 
(sLex and Slea; no Lex) at 4 uM; F: COLO205 at 8 uM. The bar graph is the same data in 
pixels.
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Boron distances of compound 6a and compound 6b.
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Synthesis of boronic acid compounds 6a and 6b: i) 2a or 2b, EDCI, HOBt, DIEA, CH2Cl2; 
ii) TFA/ CH2Cl2 (1:2, v/v); iii) 4, K2CO3, CH3CN; iv) (CH3CH2)2NH/ CH2Cl2 (1:1, v/v).
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